The relationship between Chlamydophila pneumoniae IgG titer and coronary atherosclerosis

Cardiology Journal

Volumn 15, Issue 3, 2008, Pages 245-251

  Kalay, Nihat ^a,c   Kutukoglu, Ilker ^b   Ozdogru, Ibrahim ^b   Kilic, Huseyin ^b   Cetinkaya, Yakup ^b   Eryol, Namik Kemal ^b   Karakaya, Ekrem ^b   Oguzhan, Abdurrahman ^b  

^a Sorgun Devlet Hastanesi   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^c Kardiyoloji ABD38039 ^*  (Turkey)

Author keywords

Atherosclerosis; Chlamdophila pneumoniae; Gensini and extent score

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ANGIOGRAPHY; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; AGED; ANGIOCARDIOGRAPHY; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITALIZATION; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED;

AGED; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 54049153301     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Tiong AY, Brieger D. Inflammation and coronary artery disease. Am Heart J, 2005; 150: 11-18.
2. Dittrich R, Dragonas C, Mueller A et al. Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL. Biochem Biophys Res Communic, 2004; 319: 501-505.
3. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl, 2005; 6: 21-29.
4. Muhlestein JB, Anderson JL. Chronic infection and coronary artery disease. Cardiol Clin, 2003; 21: 333-362.
5. Romano S, Penco M, Fratini S et al. Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability. Internat J Cardiol, 2004; 95: 95-99.
6. Yetkin G, Yetkin E, Aksoy Y, Gurbuz OA, Mert A. Changes in antibody titers against Chlamydia pneumoniae after coronary angioplasty. Internat J Cardiol, 2004; 95: 293-297.
7. Pitiriga VC, Kotsis VT, Gennimata V et al. Chlamydia pneumoniae and Epstein-Barr Antibodies Are not Associated With Carotid Thickness: The Effect of Hypertension. AJH, 2003; 16: 777-780.
8. Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, 1988; 2: 983-986.
9. Ericson K, Saldeen TG, Lindquist O, Pahlson C, Mehta JL. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation, 2000; 101: 2568-2571.
10. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation, 1997; 96: 404-407.
11. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomized trial of roxitromycin in non-Q wave coronary syndromes: ROXIS pilot study. Lancet, 1997; 350: 404-407.
12. Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes - the final report of the ROXIS study. Eur Heart J, 1999; 20: 121-127.
13. Dunne MW. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax-azithromycin-for atherosclerosis and its related disorders) trial. J Infect Dis, 2000; 181: 572-578.
14. Morrow DA, Antman EM, Charlesworth A et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation, 2000; 102: 2031-2037.
15. Braunwald E. Unstable angina. A classification. Circulation, 1989; 80: 410-414.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem, 1972; 18: 499-502.
17. Vainas T, De Graaf R, Stassen FR et al. Chlamydia pneumoniae serology: Comparing a commercial enzyme immunoassay and microimmunofluorescence test in patients with cardiovascular disease. APMIS, 2003; 111: 363-369.
18. Ossewaarde JM, Tuuminen T, Boersma WG, Sandstrom M, Palomaki P, Boman J. A preliminary evaluation of a new enzyme immunoassay to detect Chlamydia pneumoniae-specific antibodies. J Microbiol Methods, 2000; 43: 117-125.
19. Tuuminena T, Palomakia P, Paavonen J. The use of serologic tests for the diagnosis of chlamydial infections. J Microbiol Methods, 2000; 42: 265-279.
20. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983; 51: 606-607.
21. Enbergs A, Burger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S. Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy Eur Heart J, 2000; 21: 45-52.
22. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J, 1990; 119: 1262-1267.
23. Arno G, Kaski JC, Smith DA, Akiyu JP, Hughes SE, Baboonian C. Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques. Heart, 2005; 91: 521-525.
24. Imai S, Matsubara T, Hori T et al. Relationship of Chlamydia pneumoniae infection to severity of coronary atherosclerosis in patients with chronic coronary artery disease and with normal coronary arteries. J Cardiol, 2001; 37: 293-299.
25. Wang SS, Tondella ML, Bajpai A et al. Circulating Chlamydia pneumoniae DNA and advanced coronary artery disease. Int J Cardiol, 2007; 118: 215-219.
26. Yavuz MT, Yavuz O, Yazici M et al. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis. Scand J Clin Lab Invest, 2006; 66: 523-534.
27. Videm V, Wiseth R, Gunnes S, Madsen HO, Garred P. Multiple inflammatory markers in patients with significant coronary artery disease. Int J Cardiol, 2007; 118: 81-87.
28. Zhang L, Ishikawa Y, Akasaka Y, Ito K, Gregory S, Ishii T. Limited association of Chlamydia pneumoniae detection with coronary atherosclerosis. Atherosclerosis, 2003; 167: 81-88.
29. Markus HS, Sitzer M, Carrington D, Mendall MA, Steinmetz H. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation, 1999; 100: 832-837.
30. Ericson K, Saldeen TG, Lindquist O, Pahlson C, Mehta JL. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation, 2000; 101: 2568-2571.
31. Anderson JL, Carlquist JF, Muhlestein JB, Horne BJ, Elmer SP. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol, 1998; 32: 35-41.
32. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation, 1999; 99: 1161-1164.
33. el-Rabadi K, Gottsauner-Wolf M, Christ G, Maurer G, Huber K. Chlamydia antibody titers in patients with coronary disease: Relations to age and clinical stage. Wien Klin Wochenschr, 2001; 113: 727-730.
34. de Maat MP, Ossewaarde JM, Verheggen PW, Kluft C, Cats VM, Haverkate F. Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris. Atherosclerosis, 2000; 153: 499-504.
35. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation, 1999; 99: 1161-1164.
36. Liu R, Moroi M, Yamamoto M et al. Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int Heart J, 2006; 47: 511-519.
37. Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: A meta-analysis of randomized controlled trials. JAMA, 2005; 293: 2641-2647.